Risk factors for a severe form of COVID‐19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM‐TC) multicentre cohort study - Université de Lorraine
Journal Articles British Journal of Haematology Year : 2021

Risk factors for a severe form of COVID‐19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM‐TC) multicentre cohort study

Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.

Maud d'Aveni
Yves Chalandon
Xavier Poiré
Fichier principal
Vignette du fichier
Covid-allo_BJH_HAL.pdf (613.99 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03377871 , version 1 (14-10-2021)

Identifiers

Cite

Alienor Xhaard, Constance Xhaard, Maud d'Aveni, Helene Salvator, Marie-Laure Chabi, et al.. Risk factors for a severe form of COVID‐19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM‐TC) multicentre cohort study. British Journal of Haematology, 2021, 192 (5), pp.e121-e124. ⟨10.1111/bjh.17260⟩. ⟨hal-03377871⟩
66 View
65 Download

Altmetric

Share

More